Accompanying editorial calls for further refinements in value-based insurance design to reduce unintended use of low-value care, reports the latest issue of The American Journal of Managed Care®. May 14, 2019 10:40 AM Eastern Daylight Time CRANBURY, N.J.–(BUSINESS WIRE)–When a large national employer removed cost sharing for primary care visits, medical utilization fell, as did […]

January 23, 2019 – At more than $54 billion, spending to treat all orthopedic pain conditions (including pain in the muscles, bones and joints) represents more than 14 percent of overall healthcare spending for commercially insured adult Blue Cross Blue Shield (BCBS) members.1,2 This report identifies trends in cost and quality of care for elective […]

Real-world study compares Ozempic® (semaglutide) to other standard diabetes therapies October 17, 2018 09:00 AM Eastern Daylight Time WILMINGTON, Del.–(BUSINESS WIRE)–HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. (NYSE: ANTM) and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind […]